SPDR S&P Biotech ETF $XBI Stock: Madrona Financial Services LLC Reduces Position

Madrona Financial Services LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 131,913 shares of the exchange traded fund’s stock after selling 4,542 shares during the period. SPDR S&P Biotech ETF accounts for approximately 3.2% of Madrona Financial Services LLC’s investment portfolio, making the stock its 8th biggest holding. Madrona Financial Services LLC owned approximately 0.19% of SPDR S&P Biotech ETF worth $20,800,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in XBI. Vertrix Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 5.0% in the third quarter. Vertrix Wealth Management LLC now owns 1,503 shares of the exchange traded fund’s stock valued at $237,000 after purchasing an additional 71 shares in the last quarter. Compound Planning Inc. raised its holdings in SPDR S&P Biotech ETF by 0.7% during the first quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after purchasing an additional 75 shares in the last quarter. PeakShares LLC raised its holdings in SPDR S&P Biotech ETF by 5.2% during the first quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock worth $215,000 after purchasing an additional 84 shares in the last quarter. Robertson Stephens Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 0.5% during the third quarter. Robertson Stephens Wealth Management LLC now owns 21,640 shares of the exchange traded fund’s stock worth $3,412,000 after purchasing an additional 99 shares in the last quarter. Finally, Centaurus Financial Inc. raised its holdings in SPDR S&P Biotech ETF by 11.4% during the first quarter. Centaurus Financial Inc. now owns 1,254 shares of the exchange traded fund’s stock worth $160,000 after purchasing an additional 128 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 1.4%

Shares of NYSEARCA:XBI opened at $149.54 on Friday. The company has a market capitalization of $10.17 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a twelve month low of $106.30 and a twelve month high of $169.89. The firm has a 50 day simple moving average of $157.40 and a 200-day simple moving average of $147.73.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.